UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other juri ...

Definitive Healthcare Corp. (NASDAQ:DH) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Matt Ruderman – Chief Legal Officer Robert Musslewhite – Chief Executive Officer Jason Krantz – Founder and Executive Chairman Rick Booth – Chief Financial Officer Conference Call Participants Jared Haase – William Blair Matt Shea – Needham & Co. Craig Hettenbach – Morgan Stanley Joe Vruwink – Baird David Grossman – Stifel Allen Lutz – Bank of America Johnathan McCary – Raymond James Jonathan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jur ...

公司使命和竞争优势 - 公司的使命是将数据、分析和专业知识转化为医疗商业智能，帮助客户发现正确的市场、机会和人才，塑造未来的医疗行业[20] - 公司是领先的医疗商业智能提供商，通过SaaS平台提供准确和全面的医疗提供者信息，帮助客户优化从产品开发到市场规划、销售和营销执行的一切[21] - 公司的竞争优势包括建立了12年的全面数据集、应用数据科学创造了独有的智能和联系，以及提供客户访问答案而非数据的用户界面[24] 公司发展策略 - 公司的增长策略包括获取新客户、扩大与现有客户的关系、持续创新以加强平台和市场领导地位、进行有选择性的战略收购和投资[30] 公司客户群体 - 公司的客户群体包括销售或竞争医疗生态系统的公司，包括生命科学、医疗信息技术、医疗提供者等各种公司[31] 公司人力资本和文化 - 公司的人力资本包括974名员工，其中30%远程工作，涵盖销售、市场、产品开发等各个领域[33] - 公司致力于多样性、公平和包容，通过员工亲和力团体提供一个共同分享经验的平台[36] - 公司提供竞争力的薪酬和福利，支持员工和家人，吸引顶尖人才，确保薪酬公平[37] - 公司提供员工发展和晋升机会，通过绩效评估和目标设定来促进员工成长和晋升[38] 公司风险管理 - 公司的市场风险主要受通货膨胀、利率或汇率变化的影响[210] - 公司的外汇风险主要来自瑞典和印度的子公司，但目前外汇汇率对历史业绩影响不大[211] - 公司认为通货膨胀对业务、财务状况或运营结果没有实质影响[212]

Definitive Healthcare Corp. (NASDAQ:DH) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Matt Ruderman - General Counsel Robert Musslewhite - CEO Jason Krantz - Chairman Rick Booth - CFO Conference Call Participants David Grossman - Stifel Craig Hettenbach - Morgan Stanley Jacob Staffel - Goldman Sachs Matt Shea - Needham Ryan Shanahan - Canaccord Genuity Glen Santangelo - Jefferies Brian Peterson - Raymond James Anne Samuel - JPMorgan Allen Lutz - Bank of America Operator ...